Insight Molecular Diagnostics (IMDX) Revenue & Revenue Breakdown
Insight Molecular Diagnostics Revenue Highlights
Latest Revenue (Y)
$4.05M
Latest Revenue (Q)
$32.00K
Main Segment (Y)
Laboratory Services
Main Geography (Y)
UNITED STATES
Insight Molecular Diagnostics Revenue by Period
Insight Molecular Diagnostics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $4.05M | 115.58% |
| 2024-12-31 | $1.88M | 25.15% |
| 2023-12-31 | $1.50M | 56.89% |
| 2022-12-31 | $958.00K | -56.41% |
| 2021-12-31 | $2.20M | 80.76% |
| 2020-12-31 | $1.22M | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | - |
Insight Molecular Diagnostics generated $4.05M in revenue during NA 2025, up 115.58% compared to the previous quarter, and up 333.47% compared to the same period a year ago.
Insight Molecular Diagnostics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $32.00K | -97.19% |
| 2025-12-31 | $1.14M | 338.08% |
| 2025-09-30 | $260.00K | -49.81% |
| 2025-06-30 | $518.00K | -75.77% |
| 2025-03-31 | $2.14M | 43.88% |
| 2024-12-31 | $1.49M | 1192.17% |
| 2024-09-30 | $115.00K | 10.58% |
| 2024-06-30 | $104.00K | -40.91% |
| 2024-03-31 | $176.00K | -43.95% |
| 2023-12-31 | $314.00K | -26.81% |
| 2023-09-30 | $429.00K | -7.34% |
| 2023-06-30 | $463.00K | 55.89% |
| 2023-03-31 | $297.00K | 8.39% |
| 2022-12-31 | $274.00K | 308.96% |
| 2022-09-30 | $67.00K | -71.73% |
| 2022-06-30 | $237.00K | -37.63% |
| 2022-03-31 | $380.00K | -89.41% |
| 2021-12-31 | $3.59M | 264.74% |
| 2021-09-30 | $984.00K | -51.53% |
| 2021-06-30 | $2.03M | 80.60% |
| 2021-03-31 | $1.12M | 123.46% |
| 2020-12-31 | $503.00K | -9.37% |
| 2020-09-30 | $555.00K | 288.11% |
| 2020-06-30 | $143.00K | 793.75% |
| 2020-03-31 | $16.00K | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | - |
Insight Molecular Diagnostics generated $32.00K in revenue during Q1 2026, up -97.19% compared to the previous quarter, and up 2.15% compared to the same period a year ago.
Insight Molecular Diagnostics Revenue Breakdown
Insight Molecular Diagnostics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 |
|---|---|---|
| Laboratory Services | $4.03M | - |
| Pharma Services | - | $1.86M |
Insight Molecular Diagnostics's latest annual revenue breakdown by segment (product or service), as of Dec 25: Laboratory Services (100.00%).
Quarterly Revenue by Product
| Product/Service | Mar 26 | Dec 25 | Jun 25 | Mar 25 |
|---|---|---|---|---|
| Laboratory Services | $32.00K | $3.54M | $494.00K | - |
| Pharma Services | - | - | - | $2.14M |
Insight Molecular Diagnostics's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Laboratory Services (100.00%).
Insight Molecular Diagnostics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 | Dec 24 |
|---|---|---|
| Europe | $24.00K | - |
| UNITED STATES | $4.03M | $1.67M |
| Asia Pacific | - | $145.00K |
| GERMANY | - | $18.00K |
Insight Molecular Diagnostics's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (99.41%), and Europe (0.59%).
Quarterly Revenue by Country
| Country | Mar 26 | Dec 25 | Jun 25 | Mar 25 |
|---|---|---|---|---|
| UNITED STATES | $32.00K | $1.40M | $494.00K | $2.14M |
| Europe | - | - | $24.00K | - |
Insight Molecular Diagnostics's latest quarterly revenue breakdown by geography, as of Mar 26: UNITED STATES (100.00%).
Insight Molecular Diagnostics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CDXS | Codexis | $70.39M | $15.25M |
| SGMO | Sangamo Therapeutics | $57.80M | $1.44M |
| IVVD | Invivyd | $53.43M | $13.74M |
| OABI | OmniAb | $18.67M | $14.43M |
| PRLD | Prelude Therapeutics | $12.14M | $4.58M |
| IMDX | Insight Molecular Diagnostics | $4.05M | $32.00K |
| MIST | Milestone Pharmaceuticals | $1.55M | $238.00K |
| CCCC | C4 Therapeutics | - | - |
| PEPG | PepGen | - | - |